152
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Hand Grip Strength and Likelihood of Moderate-to-Severe Airflow Limitation in the General Population

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 1237-1245 | Published online: 25 May 2022

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Available from: http://www.goldcopd.org. Accessed December 15, 2021.
  • Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.00128008
  • Houben-Wilke S, Augustin IM, Vercoulen JH, et al. COPD stands for complex obstructive pulmonary disease. Eur Respir Rev. 2018;27(148):180027. doi:10.1183/16000617.0027-2018
  • Maltais F, Decramer M, Casaburi R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–62. doi:10.1164/rccm.201402-0373ST
  • Costa TM, Costa FM, Moreira CA, Rabelo LM, Boguszewski CL, Borba VZ. Sarcopenia in COPD: relationship with COPD severity and prognosis. J Bras Pneumol. 2015;41(5):415–421. doi:10.1590/s1806-37132015000000040
  • Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006;173(1):79–83. doi:10.1164/rccm.200506-969OC
  • Pothirat C, Chaiwong W, Phetsuk N, et al. The relationship between body composition and clinical parameters in chronic obstructive pulmonary disease. J Med Assoc Thai. 2016;99(4):386–393.
  • Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003;58(9):752–756. doi:10.1136/thorax.58.9.752
  • Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137(4):231–243. doi:10.1067/mlc.2001.113504
  • Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169
  • Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr. 2014;33(5):737–748. doi:10.1016/j.clnu.2014.03.007
  • Evans RA, Morgan MD. The systemic nature of chronic lung disease. Clin Chest Med. 2014;35(2):283–293. doi:10.1016/j.ccm.2014.02.009
  • Jones SE, Maddocks M, Kon SS, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70(3):213–218. doi:10.1136/thoraxjnl-2014-206440
  • Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:669–675. doi:10.2147/copd.S130790
  • Hwang JA, Kim YS, Leem AY, et al. Clinical implications of sarcopenia on decreased bone density in men with COPD. Chest. 2017;151(5):1018–1027. doi:10.1016/j.chest.2016.12.006
  • Birman MV, Solomon GS, Vender MI. Functional capacity evaluation in hand surgery. J Hand Surg Am. 2016;41(1):133–134. doi:10.1016/j.jhsa.2015.11.008
  • Granic A, Jagger C, Davies K, et al. Effect of dietary patterns on muscle strength and physical performance in the very old: findings from the Newcastle 85+ study. PLoS One. 2016;11(3):e0149699. doi:10.1371/journal.pone.0149699
  • Springstroh KA, Gal NJ, Ford AL, Whiting SJ, Dahl WJ. Evaluation of handgrip strength and nutritional risk of congregate nutrition program participants in Florida. J Nutr Gerontol Geriatr. 2016;35(3):193–208. doi:10.1080/21551197.2016.1209146
  • Park YB, Yoo KH. The current status of chronic obstructive pulmonary disease awareness, treatments, and plans for improvement in South Korea: a narrative review. J Thorac Dis. 2021;13(6):3898–3906. doi:10.21037/jtd-21-172
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. TRD. 2005;58(3):230–242. doi:10.4046/trd.2005.58.3.230
  • The EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi:10.1016/0168-8510(90)90421-9
  • Lee YK, Nam HS, Chuang LH, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009;12(8):1187–1193. doi:10.1111/j.1524-4733.2009.00579.x
  • Park S, Ham J-O, Lee B-K. Effects of total vitamin A, vitamin C, and fruit intake on risk for metabolic syndrome in Korean women and men. Nutrition. 2015;31(1):111–118. doi:10.1016/j.nut.2014.05.011
  • Armstrong T, Bull F. Development of the world health organization global physical activity questionnaire (GPAQ). J Public Health. 2006;14(2):66–70. doi:10.1007/s10389-006-0024-x
  • An KY. Comparison between walking and moderate-to-vigorous physical activity: associations with metabolic syndrome components in Korean older adults. Epidemiol Health. 2020;42:e2020066. doi:10.4178/epih.e2020066
  • Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423–429. doi:10.1093/ageing/afr051
  • Lee YL, Lee BH, Lee SY. Handgrip strength in the Korean population: normative data and cutoff values. Ann Geriatr Med Res. 2019;23(4):183–189. doi:10.4235/agmr.19.0042
  • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–1357. doi:10.1097/01.hjh.0000431740.32696.cc
  • American Diabetes Association. Standards of medical care in diabetes–2013. Diabetes Care. 2013;36(Suppl1):S11–S66. doi:10.2337/dc13-S011
  • Martinez CH, Diaz AA, Meldrum CA, et al. Handgrip strength in chronic obstructive pulmonary disease. associations with acute exacerbations and body composition. Ann Am Thorac Soc. 2017;14(11):1638–1645. doi:10.1513/AnnalsATS.201610-821OC
  • Holden M, Fyfe M, Poulin C, et al. Handgrip strength in people with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Phys Ther. 2021;101(6). doi:10.1093/ptj/pzab057
  • Marino DM, Marrara KT, Ike D, De Oliveira AD Jr, Jamami M, Di Lorenzo VA. Study of peripheral muscle strength and severity indexes in individuals with chronic obstructive pulmonary disease. Physiother Res Int. 2010;15(3):135–143. doi:10.1002/pri.454
  • Rhee CK, Kim K, Yoon HK, et al. Natural course of early COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:663–668. doi:10.2147/copd.S122989
  • Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Prevalence LP. Characteristics, and prognosis of early chronic obstructive pulmonary disease. the Copenhagen general population study. Am J Respir Crit Care Med. 2020;201(6):671–680. doi:10.1164/rccm.201908-1644OC
  • Gea J, Barreiro E, Orozco-Levi M. Free radicals, cytokines, and respiratory muscles in COPD patients. Clin Pulm Med. 2007;14(3):117–126. doi:10.1097/CPM.0b013e3180575dcd
  • Barreiro E, Peinado VI, Galdiz JB, et al. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med. 2010;182(4):477–488. doi:10.1164/rccm.200908-1220OC
  • Decramer M, de Bock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153(6 Pt 1):1958–1964. doi:10.1164/ajrccm.153.6.8665061
  • van den Borst B, Koster A, Yu B, et al. Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax. 2011;66(11):961–969. doi:10.1136/thoraxjnl-2011-200010
  • Puhan MA, Siebeling L, Zoller M, Muggensturm P, ter Riet G. Simple functional performance tests and mortality in COPD. Eur Respir J. 2013;42(4):956–963. doi:10.1183/09031936.00131612
  • Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12(7):433–450. doi:10.1007/bf02982704
  • Perrot L, Greil A, Boirie Y, et al. Prevalence of sarcopenia and malnutrition during acute exacerbation of COPD and after 6 months recovery. Eur J Clin Nutr. 2020;74(11):1556–1564. doi:10.1038/s41430-020-0623-6
  • Greening NJ, Harvey-Dunstan TC, Chaplin EJ, et al. Bedside assessment of quadriceps muscle by ultrasound after admission for acute exacerbations of chronic respiratory disease. Am J Respir Crit Care Med. 2015;192(7):810–816. doi:10.1164/rccm.201503-0535OC
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
  • Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest. 2007;132(1):164–169. doi:10.1378/chest.06-2789
  • Schols AM, Ferreira IM, Franssen FM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014;44(6):1504–1520. doi:10.1183/09031936.00070914